Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Sep;62(3):364–367. doi: 10.1038/bjc.1990.298

The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.

S R Musk 1, G G Steel 1
PMCID: PMC1971459  PMID: 2169851

Abstract

A human bladder carcinoma cell line was irradiated at high and low dose rates and exposed to camptothecin and VP16, inhibitors of topoisomerase I and topoisomerase II respectively. Although camptothecin substantially modified the cytotoxic effects of high dose rate irradiation, abolished low dose rate sparing and inhibited the repair of sublethal and potentially lethal damage, VP16 had no effect on the survival curves even at highly cytotoxic doses. Thus, it is argued that there is a role for topoisomerase I but not topoisomerase II in the repair of DNA damage induced by ionising radiation.

Full text

PDF
366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bohr V. A., Smith C. A., Okumoto D. S., Hanawalt P. C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell. 1985 Feb;40(2):359–369. doi: 10.1016/0092-8674(85)90150-3. [DOI] [PubMed] [Google Scholar]
  2. Chen G. L., Yang L., Rowe T. C., Halligan B. D., Tewey K. M., Liu L. F. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem. 1984 Nov 10;259(21):13560–13566. [PubMed] [Google Scholar]
  3. Cleaver J. E. Excision repair: our current knowledge based on human (xeroderma pigmentosum) and cattle cells. Johns Hopkins Med J Suppl. 1972;(1):195–121. [PubMed] [Google Scholar]
  4. Collins A., Johnson R. Novobiocin; an inhibitor of the repair of UV-induced but not X-ray-induced damage in mammalian cells. Nucleic Acids Res. 1979 Nov 10;7(5):1311–1320. doi: 10.1093/nar/7.5.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Colwill R. W., Sheinin R. ts A1S9 locus in mouse L cells may encode a novobiocin binding protein that is required for DNA topoisomerase II activity. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4644–4648. doi: 10.1073/pnas.80.15.4644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deacon J., Peckham M. J., Steel G. G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 1984 Dec;2(4):317–323. doi: 10.1016/s0167-8140(84)80074-2. [DOI] [PubMed] [Google Scholar]
  7. Downes C. S., Johnson R. T. DNA topoisomerases and DNA repair. Bioessays. 1988 Jun;8(6):179–184. doi: 10.1002/bies.950080602. [DOI] [PubMed] [Google Scholar]
  8. Downes C. S., Mullinger A. M., Johnson R. T. Action of etoposide (VP-16-123) on human cells: no evidence for topoisomerase II involvement in excision repair of u.v.-induced DNA damage, nor for mitochondrial hypersensitivity in ataxia telangiectasia. Carcinogenesis. 1987 Nov;8(11):1613–1618. doi: 10.1093/carcin/8.11.1613. [DOI] [PubMed] [Google Scholar]
  9. Downes C. S., Ord M. J., Mullinger A. M., Collins A. R., Johnson R. T. Novobiocin inhibition of DNA excision repair may occur through effects on mitochondrial structure and ATP metabolism, not on repair topoisomerases. Carcinogenesis. 1985 Sep;6(9):1343–1352. doi: 10.1093/carcin/6.9.1343. [DOI] [PubMed] [Google Scholar]
  10. Earnshaw W. C., Halligan B., Cooke C. A., Heck M. M., Liu L. F. Topoisomerase II is a structural component of mitotic chromosome scaffolds. J Cell Biol. 1985 May;100(5):1706–1715. doi: 10.1083/jcb.100.5.1706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eng W. K., Faucette L., Johnson R. K., Sternglanz R. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol Pharmacol. 1988 Dec;34(6):755–760. [PubMed] [Google Scholar]
  12. Fertil B., Malaise E. P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys. 1981 May;7(5):621–629. doi: 10.1016/0360-3016(81)90377-1. [DOI] [PubMed] [Google Scholar]
  13. Fleischmann G., Pflugfelder G., Steiner E. K., Javaherian K., Howard G. C., Wang J. C., Elgin S. C. Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6958–6962. doi: 10.1073/pnas.81.22.6958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gallo R. C., Whang-Peng J., Adamson R. H. Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J Natl Cancer Inst. 1971 Apr;46(4):789–795. [PubMed] [Google Scholar]
  15. Garg L. C., DiAngelo S., Jacob S. T. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene. Proc Natl Acad Sci U S A. 1987 May;84(10):3185–3188. doi: 10.1073/pnas.84.10.3185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Heck M. M., Hittelman W. N., Earnshaw W. C. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1086–1090. doi: 10.1073/pnas.85.4.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holm C., Goto T., Wang J. C., Botstein D. DNA topoisomerase II is required at the time of mitosis in yeast. Cell. 1985 Jun;41(2):553–563. doi: 10.1016/s0092-8674(85)80028-3. [DOI] [PubMed] [Google Scholar]
  18. Hsiang Y. H., Hertzberg R., Hecht S., Liu L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 1985 Nov 25;260(27):14873–14878. [PubMed] [Google Scholar]
  19. Jaxel C., Kohn K. W., Wani M. C., Wall M. E., Pommier Y. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Cancer Res. 1989 Mar 15;49(6):1465–1469. [PubMed] [Google Scholar]
  20. Johnstone A., McNerney R. Changes in topoisomerase I activity after irradiation of lymphoid cells. Biosci Rep. 1985 Oct-Nov;5(10-11):907–912. doi: 10.1007/BF01119903. [DOI] [PubMed] [Google Scholar]
  21. Kelland L. R., Steel G. G. Modification of radiation dose-rate sparing effects in a human carcinoma of the cervix cell line by inhibitors of DNA repair. Int J Radiat Biol. 1988 Aug;54(2):229–244. doi: 10.1080/09553008814551671. [DOI] [PubMed] [Google Scholar]
  22. Mattern M. R., Mong S. M., Bartus H. F., Mirabelli C. K., Crooke S. T., Johnson R. K. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res. 1987 Apr 1;47(7):1793–1798. [PubMed] [Google Scholar]
  23. Mattern M. R., Painter R. B. Dependence of mammalian DNA replication on DNA supercoiling. II. Effects of novobiocin on DNA synthesis in Chinese hamster ovary cells. Biochim Biophys Acta. 1979 Jul 26;563(2):306–312. doi: 10.1016/0005-2787(79)90049-2. [DOI] [PubMed] [Google Scholar]
  24. Mattern M. R., Scudiero D. A. Dependence of mammalian DNA synthesis on DNA supercoiling. III. Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid. Biochim Biophys Acta. 1981 Apr 27;653(2):248–258. doi: 10.1016/0005-2787(81)90160-x. [DOI] [PubMed] [Google Scholar]
  25. Nelson W. G., Liu L. F., Coffey D. S. Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature. 1986 Jul 10;322(6075):187–189. doi: 10.1038/322187a0. [DOI] [PubMed] [Google Scholar]
  26. Nishio A., Uyeki E. M. Inhibition of DNA synthesis in permeabilized L cells by novobiocin. Biochem Biophys Res Commun. 1982 Jun 30;106(4):1448–1455. doi: 10.1016/0006-291x(82)91276-1. [DOI] [PubMed] [Google Scholar]
  27. Rowe T. C., Wang J. C., Liu L. F. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat shock chromatin. Mol Cell Biol. 1986 Apr;6(4):985–992. doi: 10.1128/mcb.6.4.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Snyder R. D. Is DNA topoisomerase involved in the UV excision repair process? New evidence from studies with DNA intercalating and non-intercalating antitumor agents. Photochem Photobiol. 1987 Jan;45(1):105–111. doi: 10.1111/j.1751-1097.1987.tb08410.x. [DOI] [PubMed] [Google Scholar]
  29. Steel G. G., Peacock J. H. Why are some human tumours more radiosensitive than others? Radiother Oncol. 1989 May;15(1):63–72. doi: 10.1016/0167-8140(89)90119-9. [DOI] [PubMed] [Google Scholar]
  30. Uemura T., Ohkura H., Adachi Y., Morino K., Shiozaki K., Yanagida M. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell. 1987 Sep 11;50(6):917–925. doi: 10.1016/0092-8674(87)90518-6. [DOI] [PubMed] [Google Scholar]
  31. Wang J. C. DNA topoisomerases. Annu Rev Biochem. 1985;54:665–697. doi: 10.1146/annurev.bi.54.070185.003313. [DOI] [PubMed] [Google Scholar]
  32. Wani M. C., Nicholas A. W., Wall M. E. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues. J Med Chem. 1986 Nov;29(11):2358–2363. doi: 10.1021/jm00161a035. [DOI] [PubMed] [Google Scholar]
  33. Warters R. L., Lyons B. W., Kennedy K., Li T. M. Topoisomerase activity in irradiated mammalian cells. Mutat Res. 1989 Feb;216(1):43–55. doi: 10.1016/0165-1161(89)90022-8. [DOI] [PubMed] [Google Scholar]
  34. Wilkins R. J. Failure of the intercalating agent 4'-(9-acridylamino)-methanesulphon-m -anisidide to induce DNA-repair replication in cultured human cells. Mutat Res. 1983 Nov;122(2):211–216. doi: 10.1016/0165-7992(83)90061-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES